Performance and Impact of Prostate Specific Membrane Antigen-Based Diagnostics in the Management of Men with Biochemical Recurrence of Prostate Cancer and Its Role in Salvage Lymph Node Dissection

Up to 50% of patients initially treated for prostate cancer in a curative intent experience biochemical recurrence, possibly requiring adjuvant treatment. However, salvage treatment decisions, such as lymph node dissection or radiation therapy, are typically based on prostate specific antigen (PSA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Krimphove, Marieke J., Theissen, Lena H., Cole, Alexander P., Preisser, Felix, Mandel, Philipp C., Chun, Felix K.-H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Sexual Medicine and Andrology 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920066/
https://www.ncbi.nlm.nih.gov/pubmed/30929322
http://dx.doi.org/10.5534/wjmh.180133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920066/
https://www.ncbi.nlm.nih.gov/pubmed/30929322
http://dx.doi.org/10.5534/wjmh.180133

Ejemplares similares